aid: avalynpharma
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/avalynpharma.png
name: Avalynpharma
description: 'Avalyn Pharma is a clinical-stage biotechnology company developing inhaled therapies for
  rare and serious respiratory diseases, with a focus on idiopathic pulmonary fibrosis (IPF) and other
  interstitial lung diseases. Its inhaled-delivery pipeline includes AP01 (inhaled pirfenidone), AP02
  (inhaled nintedanib), and AP03 (a fixed-dose combination), aiming to deliver antifibrotic medication
  directly to lung tissue to improve efficacy while reducing systemic side effects. Backed by Norwest
  Venture Partners, the company is a therapeutics developer and publishes no public API or developer
  surface; this profile is maintained in the API Evangelist network as a company record.'
url: https://raw.githubusercontent.com/api-evangelist/avalynpharma/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- norwest-venture-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Clinical Stage
- Respiratory
- Pulmonary Fibrosis
- Inhaled Therapeutics
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/avalynpharma-domain-security.yml
- type: Website
  url: https://avalynpharma.com
- type: Support
  url: https://www.avalynpharma.com/contact/
- type: PrivacyPolicy
  url: https://www.avalynpharma.com/privacy-policy/
- type: TermsOfService
  url: https://www.avalynpharma.com/terms-of-use/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence